Nautilus Neurosciences Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 22
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $48.7M
Latest Deal Amount

Nautilus Neurosciences General Information

Description

Developer of non-steroidal anti-inflammatory medicine. The company engages in the development and sale of a prescription medicine which is use to treat migraine attacks in adults.

Contact Information

Website
www.nautilusneurosciences.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Acquirer
Assertio Therapeutics
Primary Office
  • Route 202/206
  • Bedminster Township, NJ 07921
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nautilus Neurosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Dec-2013 $48.7M 000.00 000.00 Completed Startup
3. Debt - General 05-Dec-2012 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 08-Apr-2010 $17.8M $32.2M Completed Startup
1. Early Stage VC (Series A) 23-Nov-2009 $14.5M $14.5M Completed Startup
To view Nautilus Neurosciences’s complete valuation and funding history, request access »

Nautilus Neurosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of non-steroidal anti-inflammatory medicine. The company engages in the development and sale of a prescription
Drug Discovery
Bedminster Township, NJ
22 As of 2014
000.00
00.00 0000-00-00
000000&0 000.00

000000 0

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
0000 000000000
Brisbane, CA
0 As of 0000
000.00
00000000000 000.00

0000000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
San Diego, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nautilus Neurosciences Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spiral Therapeutics Venture Capital-Backed Brisbane, CA 0 000.00 00000000000 000.00
0000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
000000 00000000000 Venture Capital-Backed Sudbury, MA 0 000.00 00000000000 000.00
000000 Formerly VC-backed Mountain View, CA 00 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Wayne, PA 00 00000 00000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Nautilus Neurosciences Executive Team (3)

Name Title Board Seat Contact Info
William Maichle Chief Executive Officer & Board Member
Neil Milano Chief Financial Officer
To view Nautilus Neurosciences’s complete executive team members history, request access »

Nautilus Neurosciences Board Members (7)

Name Representing Role Since
John Groom Self Board Member 000 0000
Peter Lankau Nautilus Neurosciences Executive Chairman of the Board 000 0000
William Maichle Nautilus Neurosciences Chief Executive Officer & Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Nautilus Neurosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nautilus Neurosciences Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Galen Partners Growth/Expansion Minority 000 0000 000000 0
Tailwind Capital PE/Buyout Minority 000 0000 000000 0
To view Nautilus Neurosciences’s complete investors history, request access »

Nautilus Neurosciences Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000000 14-Dec-2009 0000000000 Buildings and Property
000000 00000000000 24-Feb-2004 00000 00000 00 0000 Therapeutic Devices
000000 00000000000 04-Mar-2002 00000 00000 00 0000 Therapeutic Devices
Aegera Therapeutics Seed Round Therapeutic Devices
To view Nautilus Neurosciences’s complete investments history, request access »

Ready to get started?

Request a free trial

Nautilus Neurosciences Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000000000000 14-Dec-2009 0000000000 Completed
  • 2 buyers
000000 00000000000 24-Feb-2004 00000 00000 00 0000 Completed
  • 10 buyers
000000 00000000000 04-Mar-2002 00000 00000 00 0000 Completed
  • 10 buyers
Aegera Therapeutics Seed Round Completed
  • 4 buyers
To view Nautilus Neurosciences’s complete exits history, request access »